Me is proposing to reopen its bankruptcy auction to entertain a final offer from a nonprofit operated by its co-founder, casting doubt on its deal with Regeneron Pharmaceuticals.

Bankrupt genetic testing firm 23andMe is seeking to reopen bidding on its assets, including over 15 million customer DNA ...

Me has a path to a higher purchase price than the $256 million offered by biotech giant Regeneron after the genetic-testing ...

Bankrupt genetic testing company 23andMe told a U.S. bankruptcy judge on Wednesday that it wants to re-open bidding on its ...

The judge overseeing the bankruptcy of 23andMe questioned the limits proposed for a second auction that is designed to push ...

Is this tech company behind CEO's bid for 23andMe genetic data? How Anne Wojcicki's group still could snag 23andMe How Anne ...

There are a few clues about a mystery backer for Anne Wojcicki's bankruptcy bid for 23andMe, and they point toward a software ...

Me is teetering on the edge of bankruptcy and actively seeking a buyer. That buyer, unless explicitly restricted, could gain ...

The founder of 23andMe , Anne Wojcicki, has asked a U.S. judge to reopen an auction for the genetic testing company, saying ...

Regeneron will acquire 23andMe’s core assets for $256 million, ensuring customer data privacy and continuing the mission of ...

However, the purchase price point may be pointing to a decline in the value ... the pharmaceutical company is capable of providing similar services that 23andMe once did for its customers.

Genetic testing company 23andMe is being acquired, shortly after it declared bankruptcy months ago.